Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: Mechanisms of action evaluated with angiography, optical coherence tomography, and fractional flow reserve

JACC: Cardiovascular Interventions

Volumn 6, Issue 6, 2013, Pages 569-576

  Agostoni, Pierfrancesco ^a   Belkacemi, Anouar ^a   Voskuil, Michiel ^a   Nathoe, Hendrik M ^a   Doevendans, Pieter A ^a   Stella, Pieter R ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

drug eluting balloon; fractional flow reserve; in stent restenosis; optical coherence tomography

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BLOOD CLOTTING TIME; BLOOD VESSEL FUNCTION; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISSECTION; DRUG EFFECT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; FRACTIONAL FLOW RESERVE; FUNCTIONAL MORPHOLOGY; HEART MUSCLE REVASCULARIZATION; HUMAN; IMAGE QUALITY; IN-STENT RESTENOSIS; LOADING DRUG DOSE; MALE; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SILENT MYOCARDIAL ISCHEMIA; UNSTABLE ANGINA PECTORIS; VASCULAR PATENCY;

EID: 84879335999     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2012.12.132     Document Type: Article

References (19)

1. S. Bangalore, S. Kumar, and M. Fusaro Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials Circulation 125 2012 2873 2891
2. P.R. Stella, P. Elsman, and P.A. Doevendans Remise in the treatment of in-stent restenosis Eur Heart J 25 2004 898 899
3. H. Eltchaninoff, R. Koning, C. Tron, V. Gupta, and A. Cribier Balloon angioplasty for the treatment of coronary in-stent restenosis: immediate results and 6-month angiographic recurrent restenosis rate J Am Coll Cardiol 32 1998 980 984
4. R. Albiero, S. Silber, and C. Di Mario Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT) J Am Coll Cardiol 43 2004 943 949
5. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
6. G.W. Stone, S.G. Ellis, and C.D. O'Shaughnessy Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial JAMA 295 2006 1253 1263
7. G.N. Levine, E.R. Bates, and J.C. Blankenship 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 e122
8. P.R. Stella, A. Belkacemi, and R. Waksman The Valentines trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment EuroIntervention 7 2011 705 710
9. B. Scheller, C. Hehrlein, and W. Bocksch Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter Clin Res Cardiol 97 2008 773 781
10. P.R. Stella, A. Belkacemi, and C. Dubois A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial Catheter Cardiovasc Interv 80 2012 1138 1146
11. M. Unverdorben, C. Vallbracht, and B. Cremers Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 2009 2986 2994
12. G.G. Secco, N. Foin, N. Viceconte, F. Borgia, G. De Luca, and C. Di Mario Optical coherence tomography for guidance of treatment of in-stent restenosis with cutting balloons EuroIntervention 7 2011 828 834
13. R. Mehran, G.S. Mintz, and J.J. Popma Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis Am J Cardiol 78 1996 618 622
14. P.W. Radke, H.G. Klues, and P.K. Haager Mechanisms of acute lumen gain and recurrent restenosis after rotational atherectomy of diffuse in-stent restenosis: a quantitative angiographic and intravascular ultrasound study J Am Coll Cardiol 34 1999 33 39
15. K.K. Kuiper, M. Salem, S. Rotevatn, J. Mills, and J.E. Nordrehaug Implementing a best-treatment strategy with intracoronary brachytherapy for in-stent restenosis in patients at high risk for recurrence Cardiovasc Revasc Med 8 2007 9 14
16. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
17. A. Sheehy, S. Hsu, and A. Bouchard Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries Cardiovasc Diabetol 11 2012 75
18. A.C. Morton, N.D. Arnold, D.C. Crossman, and J. Gunn Response of very small (2 mm) porcine coronary arteries to balloon angioplasty and stent implantation Heart 90 2004 324 327
19. A. Belkacemi, P. Agostoni, and H.M. Nathoe First results of the DEB-AMI (Drug Eluting Balloon in Acute ST-Segment Elevation Myocardial Infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes J Am Coll Cardiol 59 2012 2327 2337